DSM-Firmenich AG (DSFIR.AS) Comparison with companies in other sectors?

DSM-Firmenich AG has a share price of 265.27M. You can analyze DSM-Firmenich AG (DSFIR.AS) competitors across different market sectors through stock heatmaps.

What are DSFIR.AS's NET and operating margins?

DSM-Firmenich AG (DSFIR.AS) operating margin is around 0.01, and net profit margin is approximately -0.01 as of the latest reports.

In what way does DSFIR.AS's earnings per share (EPS) trend reflect its financial momentum?

DSM-Firmenich AG (DSFIR.AS) EPS is 0.94 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for DSM-Firmenich AG is 94.04, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for DSM-Firmenich AG?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for DSM-Firmenich AG like P/E which is -316.57, P/B which is 1.04, and PEG which is -4.22. Compare them with sector averages to evaluate if the stock is priced fairly.

DSM-Firmenich AG

DSFIR.AS•EURONEXT

Consumer Defensive

Household & Personal Products

€88.40

€-0.56(-0.63%)

Fundamental Analysis of DSM-Firmenich AG (DSFIR.AS)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.94

P/E Ratio

94.04

ROE

-0.00%

Net Margin

-0.01%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$23.45B

Shares OutstandingTotal number of shares issued

$265.27M

Book Value/ShareNet worth per share

$85.65

Revenue/ShareAnnual revenue per share

$35.38

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.94

Net MarginNet income as percentage of revenue

-0.79%

Operating MarginOperating income as percentage of revenue

1.003%

ROEReturn on shareholders' equity

-0.33%

ROAReturn on total assets

-0.22%

ROCEReturn on capital employed

0.32%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.69

Cash/ShareCash and equivalents per share

$10.25

FCF YieldFree cash flow as percentage of market cap

1.91%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$5.00

Dividend YieldAnnual dividend as percentage of stock price

5.66%

Financial Ratios Analysis data is not available for DSFIR.ASFinancial Ratios Analysis details for DSFIR.AS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for DSFIR.ASSector Benchmarking details for DSFIR.AS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for DSM-Firmenich AG Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of DSM-Firmenich AG. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account DSM-Firmenich AG's unique business strengths and challenges.

Key Financial Metrics for DSM-Firmenich AG

For DSM-Firmenich AG, essential financial indicators include EPS 0.94, PE 94.04, and ROE -0.00. These key ratios reveal insights into DSM-Firmenich AG's profitability, valuation, and operational health. Understanding these metrics enables you to compare DSM-Firmenich AG with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of DSM-Firmenich AG

Metrics like Net Margin -0.79% and ROA -0.22% shed light on how well DSM-Firmenich AG is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether DSM-Firmenich AG can sustain its operations and continue growing in the future.

Valuation and Market Position of DSM-Firmenich AG

Using ratios such as P/B Ratio 1.04 and PEG Ratio -4.22, investors can assess whether DSM-Firmenich AG is appropriately valued based on its financials and growth potential. These figures, combined with DSM-Firmenich AG's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for DSM-Firmenich AG

Financial health indicators, such as Debt/Equity Ratio 0.23 and Cash Flow $1.69, provide a snapshot of DSM-Firmenich AG's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like DSM-Firmenich AG, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for DSM-Firmenich AG

Investing in DSM-Firmenich AG based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at DSM-Firmenich AG focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;